Related Experiment Video
Updated: Apr 25, 2026
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
A predictive risk model for medical intractability in epilepsy
Lisu Huang1, Shi Li2, Dake He1
1Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Early identification of medically intractable epilepsy is possible. Key predictors include neurological abnormalities, early onset, frequent seizures before diagnosis, and partial epilepsy, enabling timely intervention for better seizure control.
Area of Science:
- Pediatric Neurology
- Epilepsy Research
- Clinical Prediction Modeling
Background:
- Medical intractability in epilepsy poses significant challenges to patient management and quality of life.
- Identifying early predictors can facilitate timely therapeutic adjustments and improve outcomes for children with epilepsy.
Purpose of the Study:
- To investigate early predictors of medical intractability in childhood epilepsy.
- To develop and validate a predictive model for identifying children at risk of intractable epilepsy.
Main Methods:
- A cohort of children under 12 years with epilepsy was retrospectively analyzed.
- Medical intractability was defined by failure to control seizures despite adequate antiepileptic drug trials.
- Logistic regression and ROC curve analysis were used to identify risk factors and build a predictive model.
Main Results:
- 18% of patients developed medically intractable epilepsy within two years of diagnosis.
- Significant independent risk factors for intractable epilepsy included neurodevelopmental delay, symptomatic etiology, partial seizures, and >10 seizures pre-diagnosis.
- A predictive model incorporating neurological abnormality, age at onset <1 year, >10 seizures pre-diagnosis, and partial epilepsy demonstrated good predictive accuracy (AUC=0.7797).
Conclusions:
- A simple, four-characteristic model effectively predicts medical intractability in childhood epilepsy.
- This model can aid clinicians in early identification and management of children at risk for intractable epilepsy.
- The predictive model showed efficacy even in patients with idiopathic epilepsy syndromes.
Objective:
This study aimed to investigate early predictors (6 months after diagnosis) of medical intractability in epilepsy.
Methods:
All children <12 years of age having two or more unprovoked seizures 24 h apart at Xinhua Hospital between 1992 and 2006 were included. Medical intractability was defined as failure, due to lack of seizure control, of more than 2 antiepileptic drugs at maximum tolerated doses, with an average of more than 1 seizure per month for 24 months and no more than 3 consecutive months of seizure freedom during this interval. Univariate and multivariate logistic regression models were performed to determine the risk factors for developing medical intractability. Receiver operating characteristic curve was applied to fit the best compounded predictive model.
Results:
A total of 649 patients were identified, out of which 119 (18%) met the study definition of intractable epilepsy at 2 years after diagnosis, and the rate of intractable epilepsy in patients with idiopathic syndromes was 12%. Multivariate logistic regression analysis revealed that neurodevelopmental delay, symptomatic etiology, partial seizures, and more than 10 seizures before diagnosis were significant and independent risk factors for intractable epilepsy. The best model to predict medical intractability in epilepsy comprised neurological physical abnormality, age at onset of epilepsy under 1 year, more than 10 seizures before diagnosis, and partial epilepsy, and the area under receiver operating characteristic curve was 0.7797. This model also fitted best in patients with idiopathic syndromes.
Conclusion:
A predictive model of medically intractable epilepsy composed of only four characteristics is established. This model is comparatively accurate and simple to apply clinically.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
01:22Epilepsy ll: Types
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
01:24Drug Toxicity: Risk factors